University of Wisconsin–Madison

William J Burlingham, PhD

Professor

  • Division of Transplantation

burlingham@surgery.wisc.edu
(608) 263-0388

600 Highland Ave
MC 7375
Madison, WI 53792-3284

Education

  • PhD, Biology, Syracuse University, Syracuse, NY, 1979
  • Postdoctoral Research Fellowship, National Cancer Institute, Mayo Clinic and Mayo Medical School, Rochester, MN, 1980-1983

Research Interests

Dr. Burlingham has developed a highly respected transplant basic research program that focuses on acquired immunologic tolerance. His laboratory hopes to gain insight into graft acceptance by studying transplant recipients who have survived after stopping immunosuppressive drugs.

Specifically, his research focuses on the natural exchange of soluble antigens and low numbers of white blood cells that occurs between mother and child during pregnancy and nursing. The lab’s working hypothesis is that this exchange, which leads to persistence of bone marrow-derived maternal blood cells within the offspring (“microchimerism”) may induce a “natural” form of tolerance. This tolerance, if harnessed, may allow for drug-free acceptance of transplanted grafts. Such natural tolerance has recently been shown to be the result, not of having microchimerism per se, but having a specific type of rare maternal cells capable of producing exosomes– tiny virus-like vesicles composed of lipid, protein, and nucleic acids. The goal is now to investigate how these intercellular messengers modify the host antigen presenting cells, and T cells during tolerance, with a view toward therapeutic applications.

The other major focus of Dr. Burlingham’s lab is the phenomenon of autoimmunity that develops after lung transplantation. A novel type of T Cells, called Th-17, react to collagen type V and cause inflammation and over-production of collagens causing airway blockage and graft loss. His lab is working on ways to inhibit this process by new forms of immune suppressive drugs and by increasing T regulatory cells that normally prevent autoimmune disease.

View Dr. Burlingham’s Google Scholar Citations Profile.

Dr. Burlingham’s Lab

Recent Publications:

    • Functional characterization of human pluripotent stem cell-derived arterial endothelial cells.
    • Zhang J, Chu LF, Hou Z, Schwartz MP, Hacker T, Vickerman V, Swanson S, Leng N, Nguyen BK, Elwell A, Bolin J, Brown ME, Stewart R, Burlingham WJ, Murphy WL, Thomson JA
    • Proc. Natl. Acad. Sci. U.S.A. 2017 Jul 25; 114(30): E6072-E6078
    • [PubMed ID: 28696312]
    • Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance.
    • Bracamonte-Baran W, Florentin J, Zhou Y, Jankowska-Gan E, Haynes WJ, Zhong W, Brennan TV, Dutta P, Claas FH, van Rood JJ, Burlingham WJ
    • Proc. Natl. Acad. Sci. U.S.A. 2017 Jan 31; 114(5): 1099-1104
    • [PubMed ID: 28096390]
    • Donor-derived exosomes: the trick behind the semidirect pathway of allorecognition.
    • Morelli AE, Bracamonte-Baran W, Burlingham WJ
    • Curr Opin Organ Transplant 2017 Feb; 22(1): 46-54
    • [PubMed ID: 27898464]
    • Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.
    • Sullivan JA, Jankowska-Gan E, Hegde S, Pestrak MA, Agashe VV, Park AC, Brown ME, Kernien JF, Wilkes DS, Kaufman DB, Greenspan DS, Burlingham WJ
    • Am. J. Transplant. 2017 Apr; 17(4): 944-956
    • [PubMed ID: 27801552]
    • "Cross-Dressing" Becomes Fashionable Among Transplant Recipients.
    • Burlingham WJ
    • Am. J. Transplant. 2017 Jan; 17(1): 5-6
    • [PubMed ID: 27589607]

All Publications on PubMed